Logo-Cellfbio-Tagline-400x400 (1).jpg
Cellf BIO Begins Phase 1 Clinical Trial of BioSphincter™ Implant for Fecal Incontinence
05 janv. 2023 09h18 HE | CELLF-BIO, LLC
RICHMOND, Va., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Cellf BIO, a biotechnology company that manufactures bioengineered sphincters using autologous progenitor cells, announced today that it has begun its...
visiongain Logo.png
Mesenchymal stem cells market is projected to grow at a CAGR of 13.82% by 2032: Visiongain Reports Ltd
14 déc. 2022 06h00 HE | Visiongain Reports Ltd
Visiongain has published a new report entitled Mesenchymal Stem Cells Market 2022-2032. It includes profiles of Mesenchymal Stem Cells Market and Forecasts Market Segment by Type {Product (Cell &...
GMILogo_Vertical-Gradient.png
Bioreactors Market to hit USD 28 billion by 2032, says Global Market Insights Inc.
14 déc. 2022 02h10 HE | Global Market Insights Inc.
Selbyville, Delaware, Dec. 14, 2022 (GLOBE NEWSWIRE) -- The bioreactors market value is anticipated to garner over USD 28 billion by 2032, according to the recent research report by Global Market...
Stem Cells Market Size [2021-2028] Exhibits 12.8% CAGR to Reach USD 27.65 Billion by 2028
22 nov. 2022 04h05 HE | Fortune Business Insights
Pune, India, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Fortune Business Insights has published latest forecast for stem cells market in their report titled, “Stem Cells Market Forecast, 2021-2028”. As per...
Congress Introduced with “Access to Future Cures Act” Aimed at Enabling Precision Medicine for Future Cellular & Gene Therapies
26 sept. 2022 07h30 HE | GoodCell
Norwalk, CT, Sept. 26, 2022 (GLOBE NEWSWIRE) -- H.R.8912, the “Access to Future Cures Act,” was introduced to Congress on September 20th which aims to expand Health Savings Account (HSA), Health...
visiongain Logo.png
Mesenchymal stem cells market is projected to grow at a CAGR of 13.82% by 2032: Visiongain Research Inc
26 sept. 2022 05h15 HE | Visiongain Reports Ltd
Visiongain has published a new report entitled Mesenchymal Stem Cells Market 2022-2032. It includes profiles of Mesenchymal Stem Cells Market and Forecasts Market Segment by Type {Product (Cell &...
merakris_logo_4color copy.jpg
Merakris Sponsored Study Opens Door to Precision-Based Approaches to Wound Healing
13 sept. 2022 06h00 HE | Merakris Therapeutics
RESEARCH TRIANGLE PARK, N.C., Sept. 13, 2022 (GLOBE NEWSWIRE) -- A recently published manuscript containing research sponsored, in part, by Merakris Therapeutics has opened the door to more...
Nouveau Logo communiqué de presse.JPG
Theratechnologies TH1902 Study Published in Pharmaceutics Demonstrates Inhibition of Human Sortilin (SORT1)-Positive Ovarian and Triple-Negative Breast Cancer Stem-Like Cells and Tumor Growth
12 sept. 2022 07h30 HE | Theratechnologies
Researchers report superior anticancer activity against cancer stem-like cells with TH1902, compared to unconjugated docetaxelFirst evidence for TH1902 targeting of human breast and ovarian cancer...
Nouveau Logo communiqué de presse.JPG
L’étude sur le TH1902 de Theratechnologies publiée dans la revue Pharmaceutics montre une inhibition de la croissance des cellules de type souches cancéreuses humaines du cancer de l’ovaire et du CSTN exprimant le récepteur de la sortiline (SORT1) et de la croissance tumorale
12 sept. 2022 07h30 HE | Theratechnologies
Les chercheurs signalent une activité anticancéreuse supérieure contre les cellules de type souches cancéreuses avec le TH1902, comparativement au docétaxel non conjugué.Premières données probantes...
Featured Image for Experimental Biology and Medicine
New Study Finds Mouse Embryonic Stem Cells Have No Special Requirement for Threonine
07 sept. 2022 10h00 HE | Experimental Biology and Medicine
WASHINGTON, Sept. 07, 2022 (GLOBE NEWSWIRE) -- A recently published article in Experimental Biology and Medicine (Volume 247, Issue 15, August, 2022) challenges that mouse embryonic stem cells are...